These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 1416662)

  • 1. [Oculocutaneous albinism].
    Lacour JP; Ortonne JP
    Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculocutaneous albinism type 1A: a case report.
    Karaman A
    Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oculocutaneous albinism.
    Grønskov K; Ek J; Brondum-Nielsen K
    Orphanet J Rare Dis; 2007 Nov; 2():43. PubMed ID: 17980020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oculocutaneous and ocular albinism].
    Kubasch AS; Meurer M
    Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albinism and its implications with vision.
    Kirkwood BJ
    Insight; 2009; 34(2):13-6. PubMed ID: 19534229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism.
    Oetting WS; King RA
    Hum Mutat; 1999; 13(2):99-115. PubMed ID: 10094567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable expression of vision in sibs with albinism.
    Summers CG; Creel D; Townsend D; King RA
    Am J Med Genet; 1991 Sep; 40(3):327-31. PubMed ID: 1951438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial Oculocutaneous Albinism: Two Siblings with Features of both Hermansky Pudlak and Waardenburg's Syndrome.
    Ishaq M; Niazi MK; Khan MS; Nadeem Y
    J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S43-4. PubMed ID: 25933462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of non-syndromic and syndromic oculocutaneous albinism in human and mouse.
    Fernández A; Hayashi M; Garrido G; Montero A; Guardia A; Suzuki T; Montoliu L
    Pigment Cell Melanoma Res; 2021 Jul; 34(4):786-799. PubMed ID: 33960688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new genetic isolate with a unique phenotype of syndromic oculocutaneous albinism: clinical, molecular, and cellular characteristics.
    Schreyer-Shafir N; Huizing M; Anikster Y; Nusinker Z; Bejarano-Achache I; Maftzir G; Resnik L; Helip-Wooley A; Westbroek W; Gradstein L; Rosenmann A; Blumenfeld A
    Hum Mutat; 2006 Nov; 27(11):1158. PubMed ID: 17041891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
    Ullah MI
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism.
    Chan HW; Schiff ER; Tailor VK; Malka S; Neveu MM; Theodorou M; Moosajee M
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33808351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Might the refractive state in oculocutaneous albino patients be a clue for distinguishing between tyrosinase-positive and tyrosinase-negative forms of oculocutaneous albinism?
    Käsmann B; Ruprecht KW
    Ger J Ophthalmol; 1996 Nov; 5(6):422-7. PubMed ID: 9479530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oculocutaneous albinism, immunodeficiency, hematological disorders, and minor anomalies: a new autosomal recessive syndrome?
    Kotzot D; Richter K; Gierth-Fiebig K
    Am J Med Genet; 1994 Apr; 50(3):224-7. PubMed ID: 8042664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.